Weekly News Digest: August 20, 2021
What does Friday represent for you? Is it the end of the workweek, the time when you look ahead to some downtime with your family and friends, or just planning what to do over the upcoming weekend? Whatever you do today, one thing doesn’t change: Friday’s Weekly News Digest by Marry Jane. Below, we feature seven top news stories from the CBD and CBD-related world from the past week. Are you ready? Here we go!
1. In Italy, a study investigates how the environment can affect cannabinoid levels in cannabis varieties
Our journey this week begins in Italy. Canapa Sativa Italia, together with the Experimental Zooprophylactic Institute of Southern Italy, is conducting a research project whose main objective is to assess the production stability of cannabinoids, both in germinated plants (i.e. originating from seeds) and in plants derived from agamic replication (clones of certified varieties), through analytical evaluations performed on samples at the end of flowering.
2. Ohio legislators formally submit cannabis legalisation bill
Ohio lawmakers have formally introduced a bill to legalise the possession, production and sale of cannabis for personal use. The 180-page bill will legalise the possession of up to five ounces (about 147 mg) of cannabis for adults 21 years of age and older and allow them to grow up to twelve plants for personal use. It also includes provisions to overturn tenure and cultivation convictions that have become legal under this measure. The State Department of Commerce will be responsible for overseeing the programme and issuing cannabis business licences.
3. Decriminalisation of cannabis comes into effect in Louisiana
On August 1, the cannabis law in Louisiana went into force. And the initial results are already evident. Governor John Bell Edwards acknowledged that criminalisation has serious consequences for families and taxpayers. The legislation marks a notable expansion of the state’s limited medical cannabis programme. However, while patients can vaporise cannabis preparations with a metered-dose inhaler, they cannot access the entire flower, and smoking is prohibited.
4. Webinar on the health authorisation process for cannabis products held in Brazil
ANVISA (National Health Surveillance Agency) conducted a virtual workshop on the sanitary authorisation process for cannabis products. The meeting was coordinated by ANVISA manager João Paulo Perfeito and addressed issues related to product authorisation in the factory, ethical guidelines, technical areas and regulatory instructions for professionals and companies interested in information on sanitary matters.
5. President of Uruguay signs decree to promote development of cannabis industry in the country
Uruguay’s president, Luis Lacalle Po, has signed a decree with the aim of promoting the development of the cannabis industry and facilitating the export of raw materials and semi-finished products. Rodrigo Ferres, deputy secretary to the president, presented the new decree and announced that it would eliminate the concept of preliminary approval of research projects by the Ministry of Health. Mechanisms for obtaining export permits for raw materials and cannabis derivatives will be provided.
6. Legalisation of medical cannabis officially announced in Morocco
Morocco has enacted a law legalising the use of cannabis for medical and industrial purposes. This law, which was passed by the Ministry of the Interior, aims to regulate activities related to the cultivation, production, transportation, marketing, as well as export and import of cannabis for medical and industrial purposes, subject to the condition that permits are obtained exclusively from a specialised agency. Legalising medical cannabis in Morocco will also allow farmers to join agricultural cooperatives that will supply cannabis to producing and exporting companies.
7. Release of endocannabinoids may combat seizures but leads to stroke-like effects, research shows
And we end with a bit of scientific news for you. According to research by the team led by specialists from Stanford University and the University of Calgary in Alberta, seizures cause rapid synthesis and release of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the brain. The release of this compound helps the body suppress the root of seizure activity in the brain’s hippocampus. However, 2-AG is rapidly broken down in the body after it is released, triggering new biochemical reactions that cause blood vessels in the brain to constrict. This effect may explain the disorientation and amnesia often seen shortly after an attack.
That’s it! We hope you found our digest interesting and useful. If you’re enjoying our articles, follow our blog for more engaging content. Stay safe and have a great weekend!